greeksoup/ stock research
Stock research / United States / CL · Perfumes, Cosmetics & Other Toilet Preparations · NYSE

Colgate-Palmolive Co. (CL)

Colgate-Palmolive sells toothpaste, toothbrushes, soaps, deodorants, household cleaners and pet food. Its products are marketed in over 200 countries and territories. The company was founded in 1806 and incorporated in Delaware in 1923. There are two product segments: Oral, Personal and Home Care, and Pet Nutrition. Of worldwide net sales in 2025, oral care was 44 percent, pet nutrition 23 percent, personal care 17 percent and home care 16 percent.

Colgate-Palmolive Co.

Colgate-Palmolive sells toothpaste, toothbrushes, soaps, deodorants, household cleaners and pet food. Its products are marketed in over 200 countries and territories. The company was founded in 1806 and incorporated in Delaware in 1923. There are two product segments: Oral, Personal and Home Care, and Pet Nutrition. Of worldwide net sales in 2025, oral care was 44 percent, pet nutrition 23 percent, personal care 17 percent and home care 16 percent.

Oral care

The company describes itself as a leader in oral care, with global leadership in toothpaste and manual toothbrushes on market share data. Toothpastes are sold as Colgate, Darlie, elmex, hello, meridol, Sorriso and Tom's of Maine; toothbrushes as Colgate, Darlie, elmex and meridol; mouthwashes as Colgate, elmex and meridol. The business also supplies pharmaceutical products to dentists and other oral health professionals. Oral care is a substantial part of the company's business in Asia Pacific.

Personal care

The company reports global leadership in liquid hand soap, sold as Palmolive, Protex and Softsoap. Around that sit Irish Spring, Palmolive and Protex bar soaps, Irish Spring, Palmolive, Sanex and Softsoap shower gels, Lady Speed Stick, Sanex, Speed Stick and Tom's of Maine deodorants and antiperspirants, EltaMD, Filorga and PCA SKIN skin health products, and Palmolive shampoos and conditioners.

Home care

Dishwashing liquids under Ajax, Axion and Palmolive, household cleaners under Ajax, Fabuloso and Murphy, and fabric conditioners under Suavitel, Soupline, Fluffy and Cuddly.

Hill's Pet Nutrition

Hill's sells specialty nutrition for dogs and cats in over 80 countries and territories, mainly under three brands. Hill's Science Diet, called Hill's Science Plan in Europe, covers everyday nutrition. Hill's Prescription Diet is therapeutic food for animals at different stages of health. Prime100 is a fresh pet food brand sold to pet specialty and other retailers in Australia.

How it reaches buyers

Oral, personal and home care products go to retailers, wholesalers and distributors worldwide; pet nutrition goes through authorised pet supply retailers, veterinarians and online retailers; some products are sold direct to consumers. Selling is done by a direct sales force at the individual operating subsidiaries and business units and by distributors or brokers, supported by advertising, promotion and other marketing with growing weight on digital. Sales to Walmart and its affiliates were approximately 11 percent of net sales in 2025, and no other customer was above 10 percent. The filing describes a market increasingly defined by traditional and digital retail merging, with subscription services and direct-to-consumer businesses adding competition for attention, and notes growing dependence on certain key retailers, some with greater bargaining strength and exclusive access to their own consumer data.

Materials and competition

Most raw and packaging materials are bought from other companies and available from several sources, with no single material or supplier accounting for a large part of requirements, though certain key materials come from single or limited sources; qualifying a new supplier against industry, government or the company's own standards, including responsible sourcing, can take investment and time. Commodity inputs named are resins, essential oils, tropical oils, pulp, tallow, corn, poultry and soybeans, all subject to market price swings. Competitors are multinational and local, some with greater resources or more agility, alongside retailers' private label brands and new entrants selling direct to consumers. Trademarks are treated as material to the business and protection is sought wherever the products are sold; no single patent is treated as important to the business as a whole.

People

There were approximately 33,600 employees based in over 100 countries at the end of 2025, with over 84 percent of them outside the United States, and approximately two-thirds of what the company earns comes from markets outside the United States.

From Colgate-Palmolive's annual report on Form 10-K for the year ended 31 December 2025. The filing

Compare with another name What $10,000 in Colgate-Palmolive became

Latest results

Latest quarterQ3 FY2026ended 30 September 2026 · 10-Q filed 30 October 2026
Revenue
$5.4 billion
+4.6% on the year · +0.1% on the quarter
Q4 FY2024Q3 FY2026
Net income
$751 million
+2.2% on the year · +8.4% on the quarter
Q4 FY2024Q3 FY2026
Diluted EPS
$0.94
+3.3% on the year · +9.3% on the quarter
Q4 FY2024Q3 FY2026

this quarterthe same quarter a year earlierHover a bar for its figure.

Read the Q3 FY2026 results →the 10-Q on EDGAR ↗
Last full yearFY2025ended 31 December 2025 · 10-K filed 23 February 2026
Revenue
$20.4 billion
+1.4% on the year
FY2018FY2025
Net income
$2.1 billion
-26.2% on the year
FY2018FY2025
Diluted EPS
$2.63
-25.1% on the year
FY2018FY2025

this yearthe year beforeHover a bar for its figure.

The years before, in wordsColgate-Palmolive (CL) reported revenue of $20.4 billion for fiscal 2025, the year ended 31 December 2025, up 1.4% on the year before. Net income was $2.1 billion and diluted earnings per share $2.63. Revenue was $20.1 billion in fiscal 2024, $19.5 billion in fiscal 2023, $18.0 billion in fiscal 2022 and $17.4 billion in fiscal 2021. Net income in the same years was $2.9 billion, $2.3 billion, $1.8 billion and $2.2 billion. Over the twelve months to 30 September 2026, Colgate-Palmolive reported revenue of $21.3 billion and net income of $2.1 billion. Revenue grew 4.4% a year, compounded, over the five years to fiscal 2025. Colgate-Palmolive declared $2.11 a share in dividends over the last four quarters and had 795 million shares outstanding at the latest filed count. At 30 September 2026 it carried $7.7 billion of debt and $1.5 billion of cash. At the close of 6 November 2026 the market cap of Colgate-Palmolive was $76.7 billion, 37.9 times its earnings over the last twelve months.
Read the FY2025 results →the 10-K on EDGAR ↗

Ratios

From the filings

ROE713.2%
ROCE39.5%
Operating margin14.8%
Net margin9.7%
FCF margin17.8%
Interest cover12.7x
Debt to equity26.79x
Cash conversion2.13x
Share count, last 12 months-1.4%
Sales CAGR, 3 years4.3%
Profit CAGR, 3 years6.1%
EPS, TTM$2.55

At the close of 6 November 2026

Price$96.55
Market cap$76.7 billion
Stock P/E37.9x
Price to book266.5x
EV / EBITDA21.8x
Dividend yield2.2%
Market cap / sales3.6x
52-week high$99.14
52-week low$76.11
Price, 1 year25.0%
Price CAGR, 3 years8.7%
Price CAGR, 5 years4.4%

29 ready-made ratios, from FCF yield to net debt to EBITDA, wait on the Formulas page, each with what it tells you. Browse and add them →

Worked from the filed figures; hover a name for the formula.
Read moreThe priced ones use the latest price, the last regular-hours trade on IEX. Debt to equity here stands on the borrowing lines of Colgate-Palmolive Co.'s balance sheet, added together, finance leases inside them only where the company puts them there; operating leases are a separate line. Nothing here is a valuation or a view.
CLgreeksoup.ai
Daily prices to 6 November 2026, adjusted for splits; from 28 September 2026 each day's price is the last regular-hours trade on IEX.
Read moreData provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. Day by day for the last three years; before that one point a week, carrying the week's last close and its average daily volume, so a volume bar means the same thing across the whole series; the bars sit under the price on their own scale, on the right. The moving averages need consecutive days and are drawn from the daily part. P/E is the close over the trailing four quarters' EPS as filed at each filing date, on the current share count; the dashed line is the median over the range shown. Sales and margin are quarterly revenue and the operating margin from the tables above. EV/EBITDA, price to book and market cap to sales use the latest filed balance sheet and share count at each date. Before the quarters on file begin, P/E, price to book and market cap to sales stand on each annual report from the day it was filed. Drawn in your browser; the range and overlay you pick are remembered here only.

Quarterly results

Q4 FY2021 *Q1 FY2022Q2 FY2022Q3 FY2022Q4 FY2022 *Q1 FY2023Q2 FY2023Q3 FY2023Q4 FY2023 *Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026Q3 FY2026
Revenue4,4034,3994,4844,4554,6294,7704,8224,9154,9505,0655,0585,0334,9454,9115,1105,1315,2305,3245,3615,369
Cost of revenue1,8441,8271,9301,9072,0552,0582,0352,0382,0002,0261,9921,9591,9631,9242,0412,0822,0842,0982,0652,136
Gross profit2,5592,5722,5542,5482,5742,7122,7872,8772,9503,0393,0663,0742,9822,9873,0693,0493,1463,2263,2963,233
Gross margin58%58%57%57%56%57%58%59%60%60%61%61%60%61%60%59%60%61%61%60%
SG&A1,5981,6411,6571,6341,6331,7581,7681,8221,8031,9161,9391,9791,8951,8981,9631,9712,0712,0762,1302,111
Operating income3658608849472029099741,0291,0721,0471,0921,0651,0641,0761,0801,05991.09641,0161,088
Operating margin8%20%20%21%4%19%20%21%22%21%22%21%22%22%21%21%2%18%19%20%
Interest expensen/an/an/an/an/an/an/an/an/a73.078.074.067.066.071.067.063.062.062.062.0
Pre-tax income3247958418921325618879569889671,0109869939531,0079921078929501,019
Tax rate42%24%24%24%67%26%40%22%23%25%24%21%22%24%23%23%104%24%24%24%
Net income1485596036185.0372502708718683731737738690743735-36.0646693751
Net margin3%13%13%14%0%8%10%14%15%13%14%15%15%14%15%14%-1%12%13%14%
Diluted EPS$0.17$0.66$0.72$0.74$0.01$0.45$0.60$0.86$0.87$0.83$0.89$0.90$0.90$0.85$0.91$0.91-$0.05$0.80$0.86$0.94
Operating cash flow1,1063865289696737357221,1521,1366819901,1671,2696008841,2611,4537479951,171
Capital expenditure193122178175221163184161197126117134184124108155177138128134
Free cash flow9132643507944525725389919395558731,0331,0854767761,1061,2766098671,037
Buybacks356410381104413180371332245509480295455284232288406306291330
Dividends paid496378436392485390457396506394473408514406474420523417462429
Shares outstanding840m838m834m835m830m830m827m823m821m820m817m817m813m810m808m806m801m800m797m795m
Filing10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Income statement (profit and loss)

FY2007FY2008FY2009FY2010FY2011 †FY2012FY2013 †FY2014FY2015 †FY2016 †FY2017 †FY2018FY2019FY2020FY2021 †FY2022FY2023FY2024FY2025TTM
Revenue13,79015,33015,32715,56416,73417,08517,42017,27716,03415,19515,45415,54415,69316,47117,42117,96719,45720,10120,38221,284
Cost of revenue6,0436,7046,3196,3607,1447,1537,2197,1686,6356,0726,1746,3136,3686,4547,0467,7198,1317,9408,1318,383
Gross profit7,7478,6269,0089,2049,5909,93210,20110,1099,3999,1239,2809,2319,32510,01710,37510,24811,32612,16112,25112,901
Gross margin56.2%56.3%58.8%59.1%57.3%58.1%58.6%58.5%58.6%60.0%60.0%59.4%59.4%60.8%59.6%57.0%58.2%60.5%60.1%60.6%
Research and developmentn/a240256256262259267277274289285277281290307320343355366n/a
Selling, general and administrative4,9735,4225,2825,4145,7585,9306,2235,9825,4645,1435,4005,3895,5756,0196,4076,5657,1517,7297,9038,388
Operating income2,7203,1013,6153,4893,8413,8893,5563,5572,7893,9553,7073,6943,5543,8853,3322,8933,9844,2683,3063,159
Operating margin19.7%20.2%23.6%22.4%23.0%22.8%20.4%20.6%17.4%26.0%24.0%23.8%22.6%23.6%19.1%16.1%20.5%21.2%16.2%14.8%
Interest expensen/a11510269.059.081.0119134139155156195193184120167287292267249
Pre-tax incomen/an/a3,5383,4303,7893,8743,5653,5332,7633,7383,4873,4643,3013,6473,0872,6603,3923,9563,0592,968
Income tax7599681,1411,1171,2351,2431,1551,1941,2151,1521,313906774787749693937907798793
Effective tax raten/an/a32.2%32.6%32.6%32.1%32.4%33.8%44.0%30.8%37.7%26.2%23.4%21.6%24.3%26.1%27.6%22.9%26.1%26.7%
Net income1,7371,9572,2912,2032,4312,4722,2412,1801,3842,4412,0242,4002,3672,6952,1661,7852,3002,8892,1322,054
Net margin12.6%12.8%14.9%14.2%14.5%14.5%12.9%12.6%8.6%16.1%13.1%15.4%15.1%16.4%12.4%9.9%11.8%14.4%10.5%9.7%
Diluted EPS$1.60$1.83$2.19$2.15$2.47$2.58$2.38$2.36$1.52$2.72$2.28$2.75$2.75$3.14$2.55$2.13$2.77$3.51$2.63$2.55
Filing10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K
From each year's 10-K, linked; TTM is the last four quarters.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are. † The year as the company last restated it in a later filing; rest on a figure for the one first filed. EPS is as filed.

Revenue by segment FY2011 to FY2025

FY2011FY2012FY2013FY2014FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025Share
of the parts, latest year
Total Oral, Personal and Home Care14,56214,92515,20915,02213,82212,93113,16213,15613,16813,58814,11014,25415,16715,61815,76977.4%
Pet Nutrition2,1722,1602,2112,2552,2122,2642,2922,3882,5252,8833,3113,7134,2904,4834,61322.6%
Total Oral, Personal and Home CarePet Nutrition
16.7FY201117.4FY201316.0FY201515.5FY201715.7FY201917.4FY202119.5FY202320.4FY2025

$ billion; hover a block for its figure and share

From the company's 10-Ks, in its own words (latest 10-K).
Read moreEach year's figures come from the most recent 10-K that includes that year. A year is shown only where the parts add up to the revenue above. Fiscal years are labelled by the year they end in.

Profit by segment FY2011 to FY2025

The operating profit each segment reports. Costs Colgate-Palmolive does not charge to a segment are left out, so the segments can add up to more than the company's own operating profit.

FY2011FY2012FY2013FY2014FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025Margin
FY2025
Total Oral, Personal and Home Care3,7273,8974,0834,0533,8643,8873,8413,6163,5053,5943,4953,3483,8824,0883,95925.1%
Pet Nutrition5605895635926126776776807037939018508069651,06423.1%
Total Oral, Personal and Home CarePet Nutrition
4,287FY20114,646FY20134,476FY20154,518FY20174,208FY20194,396FY20214,688FY20235,023FY2025

$ million; the figure over a bar is all the segments together. Hover a block for its profit, sales and margin.

FY2025Share of salesShare of profit
Total Oral, Personal and Home Care77%79%
Pet Nutrition23%21%

Each column adds to 100%. A segment with a bigger share of the profit than of the sales makes more on each dollar it sells.

From the company's 10-Ks, in its own words (latest 10-K).
Read moreEach year's figures come from the most recent 10-K that includes that year. A year is shown only where every segment with sales that year has an operating profit figure. A margin is a segment's operating profit over its own sales.

Cash flow

FY2007FY2008FY2009FY2010FY2011 †FY2012FY2013 †FY2014FY2015 †FY2016 †FY2017 †FY2018FY2019FY2020FY2021 †FY2022FY2023FY2024FY2025TTM
Operating cash flow2,2522,3023,2773,2112,8963,1963,2043,2982,9493,1413,0543,0563,1333,7193,3252,5563,7454,1074,1984,366
Capital expenditure583684575550537565670757691593553436335409567696705561564577
Free cash flow1,6691,6182,7022,6612,3592,6312,5342,5412,2582,5482,5012,6202,7983,3102,7581,8603,0403,5463,6343,789
Free cash flow margin12.1%10.6%17.6%17.1%14.1%15.4%14.5%14.7%14.1%16.8%16.2%16.9%17.8%20.1%15.8%10.4%15.6%17.6%17.8%17.8%
Cash from investing-528-613-841-658-1,213-865-890-859-685-499-471-1,170-2,099-779-592-1,601-742-534-817-484
Cash from financing-1,803-1,530-2,270-2,624-1,242-2,301-2,142-2,170-2,276-2,233-2,450-2,679-870-2,919-2,774-952-2,793-3,389-3,256-3,633
Depreciation and amortisation334348351376421425439442449443475511519539556545567605630643
Share-based compensationn/a100117121122120128131125123127109100107135125122135155169
Buybacks1,2691,0731,0632,0201,8061,9431,5211,5301,5511,3351,3991,2381,2021,4761,3201,3081,1281,7391,2101,333
Dividends paidn/an/a9811,1421,2031,2771,3821,4461,4931,5081,5291,5911,6141,6541,6791,6911,7491,7891,8231,831
Dividend per sharen/an/an/an/an/an/an/an/an/an/a$1.59$1.66$1.71$1.75$1.79$1.86$1.91$2.48$2.08n/a
Diluted shares, weightedn/a1,070m1,049m1,022m984m960m940m924m910m898m888m873m861m859m848m839m829m823m811m800m
Shares outstanding at period end1,018m1,003m988m990m960m936m920m907m893m883m875m863m855m850m840m830m821m813m801m795m
Filing10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K
Cash paid in the year, from the cash flow statement.
Read moreThe dividend per share is as declared. Diluted shares are the weighted average for the year; a falling count is the buybacks net of issuance. TTM sums the last four quarters; the share counts are the latest quarter's.

Balance sheet

FY2007FY2008FY2009FY2010FY2011 †FY2012FY2013 †FY2014FY2015 †FY2016 †FY2017 †FY2018FY2019FY2020FY2021 †FY2022FY2023FY2024FY2025TTM
Funded by
Shareholders' equityn/a1,9223,1162,6752,3752,1892,3051,145-299-243-60.0-10211774360940160921254.0288
Non-controlling interestn/a121141142166201231240255260303299441358362405348332311352
Debtn/a3,5853,1473,4244,8105,2305,6446,1326,5446,5206,5666,3547,8477,6017,2458,7558,5497,9497,9887,716
Operating lease liabilitiesn/an/an/an/an/an/an/an/an/an/an/an/a491476451397420456448n/a
Other liabilitiesn/a4,3514,7304,9315,3735,7745,8055,9425,4585,5865,8675,6106,1386,7426,3735,7736,4677,0977,5298,386
Total liabilities and equityn/a9,97911,13411,17212,72413,39413,98513,45911,95812,12312,67612,16115,03415,92015,04015,73116,39316,04616,33016,742
Owned
Fixed assetsn/a3,1203,5163,6933,6683,8424,0834,0803,7963,8404,0723,8813,7503,7163,7304,3074,5824,4224,6604,613
Goodwilln/a2,1522,3022,3622,4942,5002,4742,3072,1032,1072,2182,5303,5083,8243,2843,3523,4103,2723,1223,080
Intangible assetsn/a8348218311,5041,4991,4961,4131,3461,3131,3411,6372,6672,8942,4621,9201,8871,7561,5361,472
Investmentsn/an/an/an/an/an/an/an/an/an/an/an/an/an/an/an/a179160107n/a
Cash and equivalents4295556004908788849621,0899701,3151,5357268838888327759661,0961,2881,527
Receivablesn/a1,5921,6261,6101,6751,6681,6361,5521,4271,4111,4801,4001,4401,2641,2971,5041,5861,5211,6751,901
Inventoryn/a1,1971,2091,2221,3271,3651,4251,3821,1801,1711,2211,2501,4001,6731,6922,0741,9341,9872,0322,182
Other assetsn/a5301,0609641,1781,6361,9091,6361,1369668097371,3861,6611,7431,7991,8491,8321,9101,967
Total assetsn/a9,97911,13411,17212,72413,39413,98513,45911,95812,12312,67612,16115,03415,92015,04015,73116,39316,04616,33016,742
Filing10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K
At the fiscal year end; the TTM column is the latest quarter end.
Read moreBoth totals are the company's own. Other liabilities is the filed total less the rows above it: payables, deferred revenue, taxes, borrowings the rows above do not carry and the rest; other assets is the same on the other side. Investments add the current and non-current lines as filed. Debt is the company's own stated total where it files one, otherwise its long-term debt with the current maturities, never parts added together. A row is left blank in a year where the lines shown overlap and the remainder would fall below nil.

Compounded growth

10 years5 years3 yearsTTM
Sales growth, compounded2.4%4.4%4.3%5.9%
Profit growth, compounded4.4%-4.6%6.1%-29.3%
Return on equity, averagen/a1297.9%1896.2%3948.1%
Yearly growth, compounded; TTM is the last four quarters against the four before.
Read moreReturn on equity is net income over shareholders' equity at each year end, averaged over the window (the TTM column is the latest year alone); equity is the parent's shareholders' equity as tagged in the 10-K. Arithmetic on filed numbers, nothing forecast.

Questions

What was Colgate-Palmolive's revenue in fiscal 2025?

Colgate-Palmolive (CL) reported revenue of $20.4 billion for fiscal 2025, the year ended 31 December 2025, up 1.4% on the year before.

How much did Colgate-Palmolive earn in fiscal 2025?

Net income was $2.1 billion for fiscal 2025, and diluted earnings per share $2.63.

What is Colgate-Palmolive's P/E ratio?

At the close of 6 November 2026, Colgate-Palmolive traded at 37.9 times its earnings over the twelve months to 30 September 2026.

What is Colgate-Palmolive's market cap?

The market cap of Colgate-Palmolive was $76.7 billion at the close of 6 November 2026.

Does Colgate-Palmolive pay a dividend?

Yes. Colgate-Palmolive declared $2.11 a share in dividends over the four quarters to 30 September 2026.

Peers: Consumer Goods

CompanyMarket capP/EROEOp. marginSales growth
TTM		Debt to equityDiv. yield
Unilever plc UL *$143.9 billion13.6861.0%17.9%-3.8%1.683.5%
Ecolab Inc. ECL$84.3 billion40.9120.0%16.7%9.3%1.271.0%
Colgate-Palmolive Co. CL$76.7 billion37.86713.2%14.8%5.9%26.792.2%
Haleon plc HLN *$40.9 billion18.4310.1%21.9%-1.8%0.522.0%
Estee Lauder Companies Inc. EL$39.9 billion109.019.1%6.7%5.8%1.801.3%
Kenvue Inc. KVUE$37.1 billion21.9416.6%17.4%3.5%0.814.3%
SharkNinja, Inc. SN$31.4 billion37.4126.7%15.6%n/a0.22n/a
Church & Dwight Co. Inc. CHD$25.8 billion33.6417.3%18.0%1.7%0.491.1%
e.l.f. Beauty, Inc. ELF$6.9 billion80.047.1%8.9%39.9%0.67n/a
Interparfums Inc. IPAR$4.3 billion25.5419.4%17.9%2.6%0.222.4%
Coty Inc. COTY$3.6 billionn/a-18.1%-1.7%-0.2%0.88n/a
Edgewell Personal Care Co. EPC$1.3 billionn/a-6.4%-0.6%-7.0%0.882.1%
All 37 in Consumer Goods
CompanyMarket capP/EROEOp. marginSales growth
TTM		Debt to equityDiv. yield
Procter & Gamble Co. PG$383.3 billion24.9129.0%22.6%3.5%0.702.6%
Unilever plc UL *$143.9 billion13.6861.0%17.9%-3.8%1.683.5%
Ecolab Inc. ECL$84.3 billion40.9120.0%16.7%9.3%1.271.0%
Colgate-Palmolive Co. CL$76.7 billion37.86713.2%14.8%5.9%26.792.2%
Haleon plc HLN *$40.9 billion18.4310.1%21.9%-1.8%0.522.0%
Estee Lauder Companies Inc. EL$39.9 billion109.019.1%6.7%5.8%1.801.3%
Kenvue Inc. KVUE$37.1 billion21.9416.6%17.4%3.5%0.814.3%
SharkNinja, Inc. SN$31.4 billion37.4126.7%15.6%n/a0.22n/a
Church & Dwight Co. Inc. CHD$25.8 billion33.6417.3%18.0%1.7%0.491.1%
Somnigroup International Inc. SGI$13.5 billion25.6616.5%12.5%27.1%1.371.0%
Clorox Co. CLX$12.1 billion17.97n/an/a6.3%n/a5.0%
A. O. Smith Corp. AOS$8.8 billion17.9727.1%17.5%-0.7%0.372.2%
e.l.f. Beauty, Inc. ELF$6.9 billion80.047.1%8.9%39.9%0.67n/a
Interparfums Inc. IPAR$4.3 billion25.5419.4%17.9%2.6%0.222.4%
Coty Inc. COTY$3.6 billionn/a-18.1%-1.7%-0.2%0.88n/a
Harley-Davidson, Inc. HOG$3.3 billionn/a-4.4%-5.6%-14.6%0.772.3%
Imax Corp. IMAX$2.6 billion20.6327.3%26.8%28.1%0.50n/a
Whirlpool Corp. WHR$2.0 billionn/a-3.3%2.9%-6.4%1.8417.4%
Stepan Co. SCL$1.5 billion352.580.4%0.9%10.0%0.522.4%
MasterBrand, Inc. MBC$1.4 billionn/a-6.3%-2.0%12.9%0.63n/a
Edgewell Personal Care Co. EPC$1.3 billionn/a-6.4%-0.6%-7.0%0.882.1%
La-Z-Boy Inc. LZB$1.3 billion16.118.0%5.0%0.2%0.002.9%
Apogee Enterprises, Inc. APOG$957 million14.5012.8%7.2%3.0%0.642.3%
Helen of Troy Ltd. HELE$872 millionn/a-11.6%1.3%0.3%0.79n/a
Compass Diversified Holdings CODI$852 millionn/a0.1%6.0%-8.2%3.234.4%
Eastman Kodak Co. KODK$785 millionn/a-13.1%2.5%9.3%0.17n/a
Fox Factory Holding Corp. FOXF$748 millionn/a-72.4%-26.7%-2.2%0.71n/a
Movado Group Inc. MOV$693 million17.248.2%6.9%5.2%0.004.7%
Ethan Allen Interiors Inc. ETD$506 million12.868.5%7.8%-5.7%0.009.0%
Fossil Group, Inc. FOSL$461 millionn/a-77.7%-0.6%-9.1%2.26n/a
Hamilton Beach Brands Holding Co. HBB$432 million7.3226.9%12.6%1.7%0.111.5%
Flexsteel Industries Inc. FLXS$296 million11.5923.6%8.7%3.4%0.001.3%
Traeger, Inc. COOK$189 millionn/a-36.7%-7.9%-25.5%2.86n/a
Bassett Furniture Industries Inc. BSET$188 million27.464.1%2.5%1.4%0.003.7%
GoPro, Inc. GPRO$168 millionn/an/a-21.2%-23.9%n/an/a
Hooker Furnishings Corp. HOFT$156 millionn/an/an/an/a0.004.0%
LiveWire Group, Inc. LVWR$112 millionn/an/a-212.1%33.4%n/an/a
7 companies share its SEC industry code (Perfumes, Cosmetics & Other Toilet Preparations); the rest are the names nearest in size in its wider industry, Consumer Goods, one of the Fama-French 48 industries, a published grouping of SEC industry codes.
Read moreBy market capitalisation; a click on a heading sorts by it, largest first, and a second click turns it round. Each figure is the same arithmetic as the ratio box above, on each company's own filings and latest close; a name marked * is a foreign company that files once a year, on its latest fiscal year.

The public record on CL

Dividends$2.11 a share over the four quarters to 30 September 2026, a 2.19% yield
Filings21 in twelve months: 9 current reports (8-K), about 4 results of operations; 2 officer or director change; 2 other events; 1 shareholder vote; 1 exit or disposal costs
Planned insider sales15 Form 144 notices in twelve months, $60.2 million; latest 5 November 2026
Options tapeput/call 0.82 by open interest at the 6 November 2026 close; the straddle prices a 2.7% move to 13 November 2026
13F holders2,033 funds reported a position for the quarter to 30 June 2026; largest BlackRock, Inc.
Insider trading18 sales and 0 purchases on Form 4 in twelve months
Congress6 House trades disclosed in six months
Short interest17.4 million shares short, 3.53 days to cover at 15 October 2026
Documentsthe 10-K, the 10-Qs, the proxy and 4 earnings press releases, each linked

Filings

FilingPeriodFiledWhere
10-Q30 September 202630 October 2026EDGAR
10-Q30 June 202631 July 2026EDGAR
10-Q31 March 20261 May 2026EDGAR
10-K31 December 202523 February 2026EDGAR
10-Q30 September 202531 October 2025EDGAR
10-Q30 June 20251 August 2025EDGAR
10-Q31 March 202525 April 2025EDGAR
10-K31 December 202413 February 2025EDGAR
10-Q30 September 202425 October 2024EDGAR
10-Q30 June 202426 July 2024EDGAR

Reading about a stock somewhere else? Our free Chrome extension, GreekSoup Stock Ticker Lookup: Earnings, Insider Trades, 13F Holders, shows the latest quarter against a year ago, insider trades and 13F holders when you hover a $ticker such as $AAPL.